Literature DB >> 15067102

Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents.

Hideyuki Akaza1, Naoto Miyanaga, Naomi Takashima, Seiji Naito, Yoshihiko Hirao, Taiji Tsukamoto, Tomoaki Fujioka, Mitsuru Mori, Wun-Jae Kim, Jae Mann Song, Allan J Pantuck.   

Abstract

BACKGROUND: Our previous case-control study revealed that the Japanese residents in Japan could be divided into those who are able to degrade daidzein, a soybean isoflavone, to equol and those without this ability, and that the incidence of prostate cancer is higher in the latter group.
METHODS: We recently conducted a similar case-control study involving not only Japanese residents in Japan but also Korean residents in Korea. The incidence of prostate cancer in Korean residents is known to be close to that of Japanese residents in Japan. On the other hand, American residents in the United States have a markedly higher incidence of prostate cancer as compared to Japanese residents in Japan.
RESULTS: The number of subjects was 295 in Japan (133 patients and 162 controls), 122 in Korea (61 patients and 61 controls) and 45 in the United States (24 patients and 21 controls). The percentage of equol producers among patients and controls was 29% and 46% in Japan (P = 0.004) and 30% and 59% in Korea (P = 0.001), respectively. The active isoflavone level was markedly lower and the percentage of equol producers was also lower (17% for patients and 14% for controls) for Americans as compared to the Japanese and Koreans.
CONCLUSIONS: These results suggest that the ability of producing equol or equol itself is closely related to the lower incidence of prostate cancer. The results also suggest that a diet based on soybean isoflavones will be useful in preventing prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067102     DOI: 10.1093/jjco/hyh015

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  69 in total

1.  Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype.

Authors:  Kyung-Won Hong; Kwang-Pil Ko; Younjhin Ahn; Cheong-Sik Kim; Seon-Joo Park; Jae Kyung Park; Sung Soo Kim; Yeonjung Kim
Journal:  Genes Nutr       Date:  2012-04-03       Impact factor: 5.523

2.  Impact of food matrix on isoflavone metabolism and cardiovascular biomarkers in adults with hypercholesterolemia.

Authors:  Jennifer Ahn-Jarvis; Steven K Clinton; Kenneth M Riedl; Yael Vodovotz; Steven J Schwartz
Journal:  Food Funct       Date:  2012-06-27       Impact factor: 5.396

Review 3.  Equol: history, chemistry, and formation.

Authors:  Kenneth D R Setchell; Carlo Clerici
Journal:  J Nutr       Date:  2010-06-02       Impact factor: 4.798

Review 4.  Emerging research on equol and cancer.

Authors:  Johanna W Lampe
Journal:  J Nutr       Date:  2010-05-26       Impact factor: 4.798

5.  Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.

Authors:  Jennifer H Ahn-Jarvis; Steven K Clinton; Elizabeth M Grainger; Kenneth M Riedl; Steven J Schwartz; Mei-Ling T Lee; Raul Cruz-Cano; Gregory S Young; Gregory B Lesinski; Yael Vodovotz
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

6.  Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites.

Authors:  William R Wikoff; Andrew T Anfora; Jun Liu; Peter G Schultz; Scott A Lesley; Eric C Peters; Gary Siuzdak
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

7.  Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial.

Authors:  Lon S Schneider; Gerson Hernandez; Liqin Zhao; Adrian A Franke; Yu-Ling Chen; Sonia Pawluczyk; Wendy J Mack; Roberta D Brinton
Journal:  Menopause       Date:  2019-08       Impact factor: 2.953

8.  Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments.

Authors:  Jia Yao; Liqin Zhao; Zisu Mao; Shuhua Chen; Karren Carmen Wong; Jimmy To; Roberta Diaz Brinton
Journal:  Brain Res       Date:  2013-02-18       Impact factor: 3.252

Review 9.  Developing a metagenomic view of xenobiotic metabolism.

Authors:  Henry J Haiser; Peter J Turnbaugh
Journal:  Pharmacol Res       Date:  2012-08-09       Impact factor: 7.658

10.  Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers.

Authors:  M Tanaka; K Fujimoto; Y Chihara; K Torimoto; T Yoneda; N Tanaka; A Hirayama; N Miyanaga; H Akaza; Y Hirao
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-07-14       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.